ECG analytics work package
Automated analysis of resting, Holter and wearable ECG from 1 to 12 leads, with up to 300 parameters per recording.
EU Projects
Cardiolyse joins EU-funded research and innovation projects as the partner for ECG analytics, biomarkers and clinical validation — bringing a CE Class IIa platform that can take project results into real care.
Consortia need a partner who can own the ECG part of the work and turn it into something that lasts beyond the project.
Automated analysis of resting, Holter and wearable ECG from 1 to 12 leads, with up to 300 parameters per recording.
ECG- and HRV-derived biomarkers for disease progression and treatment response, including independently validated scores.
Validation study design and analysis, including sex-stratified evaluation of ECG markers.
A documented ECG API to connect project devices, apps and data platforms to the analytics.
CE Class IIa medical device software, ISO 13485 quality management, ISO 27001-aligned security and GDPR-aligned data handling.
An existing product and customer base, so project results have a direct route to deployment after the grant.
We can bring our device partners into the consortium, so the project has ECG hardware already connected to Cardiolyse analytics.
We can involve key opinion leaders in cardiology from top European organisations, to support clinical design, validation and dissemination.

H2020 pre-commercial procurement
An integrated self-management model for chronic patients in rural Europe. Cardiolyse brought heart-health screening analytics for home ECG recordings across three countries.
Read the case
Eurostars
A pocket-sized device for medical-grade 12-lead ECG, paired with Cardiolyse automated ECG interpretation, to bring full cardiac checks outside the hospital.
Read the caseWe are looking for consortia and coordinators working on these Horizon Europe Health topics, and are ready to contribute a defined ECG work package.
Certified ECG analytics behind portable and point-of-care devices, from proof of concept to clinical validation.
View call details →ECG- and HRV-derived biomarkers with sex-stratified validation for chronic non-communicable diseases.
View call details →ECG monitoring and analytics as digital read-outs inside a cardiovascular or chronic-disease intervention study.
View call details →ECG-based cardiac safety analytics, such as QT and rhythm monitoring, for polypharmacy decision support.
View call details →ECG-derived features and validation for the cardiac module of a virtual human twin.
View call details →We check the topic, the use case and where ECG analytics adds value to the project.
We agree a clear role and work package with the coordinator: tasks, deliverables and resources.
We contribute the ECG, validation and exploitation parts of the proposal.
After funding, we run the work package on our certified platform and report to the consortium.
We usually join as a partner with a defined ECG analytics, validation or integration work package, working with a coordinator who leads the consortium.
Horizon Europe, Eurostars and national innovation programmes. Past projects include CRANE (H2020), AnyECG (Eurostars), Business Finland funded projects, EIT Health projects and many more.
Point-of-care diagnostics, AI-based predictive biomarkers, interventions for non-communicable diseases, adverse drug reactions from multiple medications, and Virtual Human Twins.
Yes. We can bring our ECG device partners and key opinion leaders in cardiology from top European organisations into the consortium.
The call topic, the project concept and the role you see for ECG. We reply with a proposed work package.
Write to [email protected] or book a call.
For everything else, see the full FAQ.
Tell us the topic and the project idea. We will propose a defined ECG work package.